Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 101

1.

Trends in Rates of Infections Requiring Hospitalization Among Adults With Versus Without Diabetes in the U.S., 2000-2015.

Harding JL, Benoit SR, Gregg EW, Pavkov ME, Perreault L.

Diabetes Care. 2019 Oct 15. pii: dc190653. doi: 10.2337/dc19-0653. [Epub ahead of print]

PMID:
31615853
2.

Metabolite Profiles of Incident Diabetes and Heterogeneity of Treatment Effect in the Diabetes Prevention Program.

Chen ZZ, Liu J, Morningstar J, Heckman-Stoddard BM, Lee CG, Dagogo-Jack S, Ferguson JF, Hamman RF, Knowler WC, Mather KJ, Perreault L, Florez JC, Wang TJ, Clish C, Temprosa M, Gerszten RE; and the Diabetes Prevention Program Research Group.

Diabetes. 2019 Oct 3. pii: db190236. doi: 10.2337/db19-0236. [Epub ahead of print]

PMID:
31582408
3.

Probing the Nature of Noncovalent Interactions in Dimers of Linear Tyrosine-Based Dipeptides.

Mayes ML, Perreault L.

ACS Omega. 2019 Jan 10;4(1):911-919. doi: 10.1021/acsomega.8b02934. eCollection 2019 Jan 31.

4.

Regression From Prediabetes to Normal Glucose Regulation and Prevalence of Microvascular Disease in the Diabetes Prevention Program Outcomes Study (DPPOS).

Perreault L, Pan Q, Schroeder EB, Kalyani RR, Bray GA, Dagogo-Jack S, White NH, Goldberg RB, Kahn SE, Knowler WC, Mathioudakis N, Dabelea D; Diabetes Prevention Program Research Group.

Diabetes Care. 2019 Sep;42(9):1809-1815. doi: 10.2337/dc19-0244. Epub 2019 Jul 18.

PMID:
31320445
5.

Extended Anticoagulation for VTE: A Systematic Review and Meta-Analysis.

Mai V, Guay CA, Perreault L, Bonnet S, Bertoletti L, Lacasse Y, Jardel S, Lega JC, Provencher S.

Chest. 2019 Jun;155(6):1199-1216. doi: 10.1016/j.chest.2019.02.402.

PMID:
31174635
6.

Reversion from prediabetes to normoglycaemia and risk of cardiovascular disease and mortality: the Whitehall II cohort study.

Vistisen D, Kivimäki M, Perreault L, Hulman A, Witte DR, Brunner EJ, Tabák A, Jørgensen ME, Færch K.

Diabetologia. 2019 Aug;62(8):1385-1390. doi: 10.1007/s00125-019-4895-0. Epub 2019 May 23.

7.

Initiation and Titration of Basal Insulin in Primary Care: Barriers and Practical Solutions.

Perreault L, Vincent L, Neumiller JJ, Santos-Cavaiola T.

J Am Board Fam Med. 2019 May-Jun;32(3):431-447. doi: 10.3122/jabfm.2019.03.180162. Review.

8.

Erratum. Impact of lifestyle and metformin interventions on the risk of progression to diabetes and regression to normal glucose regulation in overweight or obese people with impaired glucose regulation. Diabetes Care 2017;40:1668-1677.

Herman WH, Pan Q, Edelstein SL, Mather KJ, Perreault L, Barrett-Connor E, Dabelea DM, Horton E, Kahn SE, Knowler WC, Lorenzo C, Pi-Sunyer X, Venditti E, Ye W; Diabetes Prevention Program Research Group.

Diabetes Care. 2019 Apr;42(4):701. doi: 10.2337/dc19-er04. No abstract available.

9.

Prediabetes.

Perreault L.

In: Feingold KR, Anawalt B, Boyce A, Chrousos G, Dungan K, Grossman A, Hershman JM, Kaltsas G, Koch C, Kopp P, Korbonits M, McLachlan R, Morley JE, New M, Perreault L, Purnell J, Rebar R, Singer F, Trence DL, Vinik A, Wilson DP, editors. Endotext [Internet]. South Dartmouth (MA): MDText.com, Inc.; 2000-.
2019 Mar 10.

10.

Ad libitum Weekend Recovery Sleep Fails to Prevent Metabolic Dysregulation during a Repeating Pattern of Insufficient Sleep and Weekend Recovery Sleep.

Depner CM, Melanson EL, Eckel RH, Snell-Bergeon JK, Perreault L, Bergman BC, Higgins JA, Guerin MK, Stothard ER, Morton SJ, Wright KP Jr.

Curr Biol. 2019 Mar 18;29(6):957-967.e4. doi: 10.1016/j.cub.2019.01.069. Epub 2019 Feb 28.

PMID:
30827911
11.

The Association Between Type 2 Diabetes and Cardiovascular Disease: The "For Your SweetHeart™" Survey.

Perreault L, Boardman MK, Pak J.

Adv Ther. 2019 Mar;36(3):746-755. doi: 10.1007/s12325-019-0871-9. Epub 2019 Feb 13.

PMID:
30758740
12.

Intermuscular adipose tissue directly modulates skeletal muscle insulin sensitivity in humans.

Sachs S, Zarini S, Kahn DE, Harrison KA, Perreault L, Phang T, Newsom SA, Strauss A, Kerege A, Schoen JA, Bessesen DH, Schwarzmayr T, Graf E, Lutter D, Krumsiek J, Hofmann SM, Bergman BC.

Am J Physiol Endocrinol Metab. 2019 May 1;316(5):E866-E879. doi: 10.1152/ajpendo.00243.2018. Epub 2019 Jan 8.

PMID:
30620635
13.

Optimizing Fixed-Ratio Combination Therapy in Type 2 Diabetes.

Perreault L, Rodbard H, Valentine V, Johnson E.

Adv Ther. 2019 Feb;36(2):265-277. doi: 10.1007/s12325-018-0868-9. Epub 2019 Jan 4. Review.

PMID:
30610613
14.

Non-traditional biomarkers and incident diabetes in the Diabetes Prevention Program: comparative effects of lifestyle and metformin interventions.

Goldberg RB, Bray GA, Marcovina SM, Mather KJ, Orchard TJ, Perreault L, Temprosa M; Diabetes Prevention Program Research Group.

Diabetologia. 2019 Jan;62(1):58-69. doi: 10.1007/s00125-018-4748-2. Epub 2018 Oct 17.

PMID:
30334082
15.

GOALS FOR MEDICAL TREATMENT IN OBESITY AND PREDIABETES: IMPROVING OUTCOMES FOR BOTH.

Perreault L.

Endocr Pract. 2018 Dec;24(12):1093-1098. doi: 10.4158/EP-2018-0316. Epub 2018 Oct 5. Review.

PMID:
30289308
16.

Selecting Core Outcomes for Randomised Effectiveness trials In Type 2 Diabetes (SCORE-IT): study protocol for the development of a core outcome set.

Harman NL, Wilding J, Curry D, Harris J, Logue J, Pemberton RJ, Perreault L, Thompson G, Tunis S, Williamson PR; SCORE-IT study team.

Trials. 2018 Aug 7;19(1):427. doi: 10.1186/s13063-018-2805-2.

17.

Where can obesity management policy make the largest impact? Evaluating sub-populations through a microsimulation approach.

Su W, Chen F, Dall TM, Zvenyach T, Kyle TK, Perreault L.

J Med Econ. 2018 Sep;21(9):936-943. doi: 10.1080/13696998.2018.1496922. Epub 2018 Jul 17.

PMID:
29973101
18.

Erratum. Impact of Lifestyle and Metformin Interventions on the Risk of Progression to Diabetes and Regression to Normal Glucose Regulation in Overweight or Obese People With Impaired Glucose Regulation. Diabetes Care 2017;40:1668-1677.

Herman WH, Pan Q, Edelstein SL, Mather KJ, Perreault L, Barrett-Connor E, Dabelea DM, Horton E, Kahn SE, Knowler WC, Lorenzo C, Pi-Sunyer X, Venditti E, Ye W; Diabetes Prevention Program Research Group.

Diabetes Care. 2018 Apr;41(4):913. doi: 10.2337/dc18-er04. Epub 2018 Feb 23. No abstract available.

19.

Intracellular localization of diacylglycerols and sphingolipids influences insulin sensitivity and mitochondrial function in human skeletal muscle.

Perreault L, Newsom SA, Strauss A, Kerege A, Kahn DE, Harrison KA, Snell-Bergeon JK, Nemkov T, D'Alessandro A, Jackman MR, MacLean PS, Bergman BC.

JCI Insight. 2018 Feb 8;3(3). pii: 96805. doi: 10.1172/jci.insight.96805. eCollection 2018 Feb 8.

20.

Impact of Lifestyle and Metformin Interventions on the Risk of Progression to Diabetes and Regression to Normal Glucose Regulation in Overweight or Obese People With Impaired Glucose Regulation.

Herman WH, Pan Q, Edelstein SL, Mather KJ, Perreault L, Barrett-Connor E, Dabelea DM, Horton E, Kahn SE, Knowler WC, Lorenzo C, Pi-Sunyer X, Venditti E, Ye W; Diabetes Prevention Program Research Group.

Diabetes Care. 2017 Dec;40(12):1668-1677. doi: 10.2337/dc17-1116. Epub 2017 Oct 11. Erratum in: Diabetes Care. 2018 Feb 23;:. Diabetes Care. 2019 Apr;42(4):701.

21.

Intramuscular triglyceride synthesis: importance in muscle lipid partitioning in humans.

Bergman BC, Perreault L, Strauss A, Bacon S, Kerege A, Harrison K, Brozinick JT, Hunerdosse DM, Playdon MC, Holmes W, Bui HH, Sanders P, Siddall P, Wei T, Thomas MK, Kuo MS, Eckel RH.

Am J Physiol Endocrinol Metab. 2018 Feb 1;314(2):E152-E164. doi: 10.1152/ajpendo.00142.2017. Epub 2017 Oct 3.

22.

Exploring residual risk for diabetes and microvascular disease in the Diabetes Prevention Program Outcomes Study (DPPOS).

Perreault L, Pan Q, Aroda VR, Barrett-Connor E, Dabelea D, Dagogo-Jack S, Hamman RF, Kahn SE, Mather KJ, Knowler WC; Diabetes Prevention Program Research Group.

Diabet Med. 2017 Dec;34(12):1747-1755. doi: 10.1111/dme.13453. Epub 2017 Sep 19.

23.

Metformin for diabetes prevention: insights gained from the Diabetes Prevention Program/Diabetes Prevention Program Outcomes Study.

Aroda VR, Knowler WC, Crandall JP, Perreault L, Edelstein SL, Jeffries SL, Molitch ME, Pi-Sunyer X, Darwin C, Heckman-Stoddard BM, Temprosa M, Kahn SE, Nathan DM; Diabetes Prevention Program Research Group.

Diabetologia. 2017 Sep;60(9):1601-1611. doi: 10.1007/s00125-017-4361-9. Epub 2017 Aug 2. Review.

24.

Can Cardiovascular Epidemiology and Clinical Trials Close the Risk Management Gap Between Diabetes and Prediabetes?

Perreault L, Færch K, Gregg EW.

Curr Diab Rep. 2017 Sep;17(9):77. doi: 10.1007/s11892-017-0899-7. Review.

PMID:
28766246
25.

EMPA-REG OUTCOME: The Endocrinologist's Point of View.

Perreault L.

Am J Cardiol. 2017 Jul 1;120(1S):S48-S52. doi: 10.1016/j.amjcard.2017.05.010. Epub 2017 May 17. Review.

26.

EMPA-REG OUTCOME: The Endocrinologist's Point of View.

Perreault L.

Am J Med. 2017 Jun;130(6S):S51-S56. doi: 10.1016/j.amjmed.2017.04.005.

27.

Functionalization of Mesoporous Carbon Materials for Selective Separation of Lanthanides under Acidic Conditions.

Perreault LL, Giret S, Gagnon M, Florek J, Larivière D, Kleitz F.

ACS Appl Mater Interfaces. 2017 Apr 5;9(13):12003-12012. doi: 10.1021/acsami.6b16650. Epub 2017 Mar 27.

PMID:
28271880
28.

Crossing kingdoms: Using decellularized plants as perfusable tissue engineering scaffolds.

Gershlak JR, Hernandez S, Fontana G, Perreault LR, Hansen KJ, Larson SA, Binder BY, Dolivo DM, Yang T, Dominko T, Rolle MW, Weathers PJ, Medina-Bolivar F, Cramer CL, Murphy WL, Gaudette GR.

Biomaterials. 2017 May;125:13-22. doi: 10.1016/j.biomaterials.2017.02.011. Epub 2017 Feb 10.

29.

Erratum to: "Change in adiponectin explains most of the change in HDL particles induced by lifestyle intervention but not metformin treatment in the diabetes prevention program" [Metabolism (2016) 65; 764-775].

Goldberg RB, Temprosa M, Mele L, Orchard T, Mather K, Bray G, Horton E, Kitabchi A, Krakoff J, Marcovina S, Perreault L, White N; Diabetes Prevention Program Research Group.

Metabolism. 2017 Mar;68:184-186. doi: 10.1016/j.metabol.2016.11.007. Epub 2017 Jan 5. No abstract available.

PMID:
28065437
30.

Functional Effects of Delivering Human Mesenchymal Stem Cell-Seeded Biological Sutures to an Infarcted Heart.

Hansen KJ, Favreau JT, Guyette JP, Tao ZW, Coffin ST, Cunha-Gavidia A, D'Amore B, Perreault LR, Fitzpatrick JP, DeMartino A, Gaudette GR.

Biores Open Access. 2016 Aug 1;5(1):249-60. doi: 10.1089/biores.2016.0026. eCollection 2016.

31.

Change in adiponectin explains most of the change in HDL particles induced by lifestyle intervention but not metformin treatment in the Diabetes Prevention Program.

Goldberg RB, Temprosa M, Mele L, Orchard T, Mather K, Bray G, Horton E, Kitabchi A, Krakoff J, Marcovina S, Perreault L, White N; Diabetes Prevention Program Research Group.

Metabolism. 2016 May;65(5):764-775. doi: 10.1016/j.metabol.2015.11.011. Epub 2015 Dec 2. Erratum in: Metabolism. 2017 Mar;68:184-186.

32.

Skeletal muscle phosphatidylcholine and phosphatidylethanolamine are related to insulin sensitivity and respond to acute exercise in humans.

Newsom SA, Brozinick JT, Kiseljak-Vassiliades K, Strauss AN, Bacon SD, Kerege AA, Bui HH, Sanders P, Siddall P, Wei T, Thomas M, Kuo MS, Nemkov T, D'Alessandro A, Hansen KC, Perreault L, Bergman BC.

J Appl Physiol (1985). 2016 Jun 1;120(11):1355-63. doi: 10.1152/japplphysiol.00664.2015. Epub 2016 Mar 31.

33.

Dietary Fatty Acids Differentially Associate with Fasting Versus 2-Hour Glucose Homeostasis: Implications for The Management of Subtypes of Prediabetes.

Guess N, Perreault L, Kerege A, Strauss A, Bergman BC.

PLoS One. 2016 Mar 21;11(3):e0150148. doi: 10.1371/journal.pone.0150148. eCollection 2016.

34.

Return on Investment for Digital Behavioral Counseling in Patients With Prediabetes and Cardiovascular Disease.

Su W, Chen F, Dall TM, Iacobucci W, Perreault L.

Prev Chronic Dis. 2016 Jan 28;13:E13. doi: 10.5888/pcd13.150357.

35.

Muscle sphingolipids during rest and exercise: a C18:0 signature for insulin resistance in humans.

Bergman BC, Brozinick JT, Strauss A, Bacon S, Kerege A, Bui HH, Sanders P, Siddall P, Wei T, Thomas MK, Kuo MS, Perreault L.

Diabetologia. 2016 Apr;59(4):785-98. doi: 10.1007/s00125-015-3850-y. Epub 2016 Jan 6.

PMID:
26739815
36.

Biomarkers of Ectopic Fat Deposition: The Next Frontier in Serum Lipidomics.

Perreault L, Starling AP, Glueck D, Brozinick JT, Sanders P, Siddall P, Kuo MS, Dabelea D, Bergman BC.

J Clin Endocrinol Metab. 2016 Jan;101(1):176-82. doi: 10.1210/jc.2015-3213. Epub 2015 Nov 17.

37.

Morning Circadian Misalignment during Short Sleep Duration Impacts Insulin Sensitivity.

Eckel RH, Depner CM, Perreault L, Markwald RR, Smith MR, McHill AW, Higgins J, Melanson EL, Wright KP Jr.

Curr Biol. 2015 Nov 16;25(22):3004-10. doi: 10.1016/j.cub.2015.10.011. Epub 2015 Nov 5.

38.

Lifestyle and Metformin Ameliorate Insulin Sensitivity Independently of the Genetic Burden of Established Insulin Resistance Variants in Diabetes Prevention Program Participants.

Hivert MF, Christophi CA, Franks PW, Jablonski KA, Ehrmann DA, Kahn SE, Horton ES, Pollin TI, Mather KJ, Perreault L, Barrett-Connor E, Knowler WC, Florez JC; Diabetes Prevention Program Research Group.

Diabetes. 2016 Feb;65(2):520-6. doi: 10.2337/db15-0950. Epub 2015 Nov 2.

39.

Serum sphingolipids: relationships to insulin sensitivity and changes with exercise in humans.

Bergman BC, Brozinick JT, Strauss A, Bacon S, Kerege A, Bui HH, Sanders P, Siddall P, Kuo MS, Perreault L.

Am J Physiol Endocrinol Metab. 2015 Aug 15;309(4):E398-408. doi: 10.1152/ajpendo.00134.2015. Epub 2015 Jun 30.

40.

Modeling the clinical and economic implications of obesity using microsimulation.

Su W, Huang J, Chen F, Iacobucci W, Mocarski M, Dall TM, Perreault L.

J Med Econ. 2015;18(11):886-97. doi: 10.3111/13696998.2015.1058805. Epub 2015 Aug 13.

PMID:
26057567
41.

Adiponectin, C-reactive protein, fibrinogen and tissue plasminogen activator antigen levels among glucose-intolerant women with and without histories of gestational diabetes.

Kim C, Christophi CA, Goldberg RB, Perreault L, Dabelea D, Marcovina SM, Pi-Sunyer X, Barrett-Connor E.

Diabet Med. 2016 Jan;33(1):32-8. doi: 10.1111/dme.12799. Epub 2015 May 29.

42.

Lean management: innovative tools for engaging teams in continuous quality improvement.

Perreault L, Vaillancourt L, Filion C, Hadj C.

Healthc Q. 2014;17(2):20-3.

PMID:
25191803
43.

Effects of weight loss, weight cycling, and weight loss maintenance on diabetes incidence and change in cardiometabolic traits in the Diabetes Prevention Program.

Delahanty LM, Pan Q, Jablonski KA, Aroda VR, Watson KE, Bray GA, Kahn SE, Florez JC, Perreault L, Franks PW; Diabetes Prevention Program Research Group.

Diabetes Care. 2014 Oct;37(10):2738-45. doi: 10.2337/dc14-0018. Epub 2014 Jul 14.

44.

Volcano-induced regime shifts in millennial tree-ring chronologies from northeastern North America.

Gennaretti F, Arseneault D, Nicault A, Perreault L, Bégin Y.

Proc Natl Acad Sci U S A. 2014 Jul 15;111(28):10077-82. doi: 10.1073/pnas.1324220111. Epub 2014 Jun 30.

45.

Regression from prediabetes to normal glucose regulation is associated with reduction in cardiovascular risk: results from the Diabetes Prevention Program outcomes study.

Perreault L, Temprosa M, Mather KJ, Horton E, Kitabchi A, Larkin M, Montez MG, Thayer D, Orchard TJ, Hamman RF, Goldberg RB; Diabetes Prevention Program Research Group.

Diabetes Care. 2014 Sep;37(9):2622-31. doi: 10.2337/dc14-0656. Epub 2014 Jun 26.

46.

Rare and low-frequency coding variants in CXCR2 and other genes are associated with hematological traits.

Auer PL, Teumer A, Schick U, O'Shaughnessy A, Lo KS, Chami N, Carlson C, de Denus S, Dubé MP, Haessler J, Jackson RD, Kooperberg C, Perreault LP, Nauck M, Peters U, Rioux JD, Schmidt F, Turcot V, Völker U, Völzke H, Greinacher A, Hsu L, Tardif JC, Diaz GA, Reiner AP, Lettre G.

Nat Genet. 2014 Jun;46(6):629-34. doi: 10.1038/ng.2962. Epub 2014 Apr 28.

47.

Hepatic glucose sensing is impaired, but can be normalized, in people with impaired fasting glucose.

Perreault L, Færch K, Kerege AA, Bacon SD, Bergman BC.

J Clin Endocrinol Metab. 2014 Jul;99(7):E1154-62. doi: 10.1210/jc.2013-3248. Epub 2014 Apr 14.

48.

Trajectories of cardiometabolic risk factors before diagnosis of three subtypes of type 2 diabetes: a post-hoc analysis of the longitudinal Whitehall II cohort study.

Færch K, Witte DR, Tabák AG, Perreault L, Herder C, Brunner EJ, Kivimäki M, Vistisen D.

Lancet Diabetes Endocrinol. 2013 Sep;1(1):43-51. doi: 10.1016/S2213-8587(13)70008-1. Epub 2013 Feb 21.

49.

Comparison of genotype clustering tools with rare variants.

Perreault LP, Legault MA, Barhdadi A, Provost S, Normand V, Tardif JC, Dubé MP.

BMC Bioinformatics. 2014 Feb 21;15:52. doi: 10.1186/1471-2105-15-52.

50.

An inherited duplication at the gene p21 Protein-Activated Kinase 7 (PAK7) is a risk factor for psychosis.

Morris DW, Pearson RD, Cormican P, Kenny EM, O'Dushlaine CT, Perreault LP, Giannoulatou E, Tropea D, Maher BS, Wormley B, Kelleher E, Fahey C, Molinos I, Bellini S, Pirinen M, Strange A, Freeman C, Thiselton DL, Elves RL, Regan R, Ennis S, Dinan TG, McDonald C, Murphy KC, O'Callaghan E, Waddington JL, Walsh D, O'Donovan M, Grozeva D, Craddock N, Stone J, Scolnick E, Purcell S, Sklar P, Coe B, Eichler EE, Ophoff R, Buizer J, Szatkiewicz J, Hultman C, Sullivan P, Gurling H, Mcquillin A, St Clair D, Rees E, Kirov G, Walters J, Blackwood D, Johnstone M, Donohoe G; International Schizophrenia Consortium, SGENE+ Consortium, O'Neill FA; Wellcome Trust Case Control Consortium 2, Kendler KS, Gill M, Riley BP, Spencer CC, Corvin A.

Hum Mol Genet. 2014 Jun 15;23(12):3316-26. doi: 10.1093/hmg/ddu025. Epub 2014 Jan 28.

Supplemental Content

Loading ...
Support Center